CNS & Neurological Disorders - Drug Targets

Formerly Current Drug Targets - CNS & Neurological Disorders

Editor-in-Chief

Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria
Messina
(Italy)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 9 Issue: 2, April

Commentary [Targeting Opioid Receptors: A New Treatment for Brain Disorders]

Volume:9   Issue: 2
Pp: 128-128
Shafiqur Rahman
DOI: 10.2174/187152710791012116
Published on: 01 March, 2012

Editorial [Hot topic: Inflammation, Immunity, and Alzheimers Disease (Guest Editor: Terrence Town)]

Volume:9   Issue: 2
Pp: 129-131
Terrence Town
DOI: 10.2174/187152710791012008
Published on: 01 March, 2012

Non-Steroidal Anti-Inflammatory Drugs and Alzheimers Disease: The Epidemiological Evidence

Volume:9   Issue: 2
Pp: 132-139
C.A. Szekely and P.P. Zandi
DOI: 10.2174/187152710791012026
Published on: 01 March, 2012

Mechanisms of Action of Non-Steroidal Anti-Inflammatory Drugs for the Prevention of Alzheimers Disease

Volume:9   Issue: 2
Pp: 140-148
Greg M. Cole and Sally A. Frautschy
DOI: 10.2174/187152710791011991
Published on: 01 March, 2012

Impact of the CD40-CD40L Dyad in Alzheimers Disease

Volume:9   Issue: 2
Pp: 149-155
Brian Giunta, Kavon Rezai-Zadeh and Jun Tan
DOI: 10.2174/187152710791012099
Published on: 01 March, 2012

Microglia and Inflammation in Alzheimers Disease

Volume:9   Issue: 2
Pp: 156-167
Shweta Mandrekar-Colucci and Gary E. Landreth
DOI: 10.2174/187152710791012071
Published on: 01 March, 2012

Mechanisms of Mononuclear Phagocyte Recruitment in Alzheimers Disease

Volume:9   Issue: 2
Pp: 168-173
Suzanne E. Hickman and Joseph El Khoury
DOI: 10.2174/187152710791011982
Published on: 01 March, 2012

Assessing Activation States in Microglia

Volume:9   Issue: 2
Pp: 174-191
Carol A. Colton and Donna M. Wilcock
DOI: 10.2174/187152710791012053
Published on: 01 March, 2012

Amyloid-β Immunotherapy for Alzheimers Disease

Volume:9   Issue: 2
Pp: 197-206
H.J. Fu, B. Liu, J.L. Frost and C.A. Lemere
DOI: 10.2174/187152710791012017
Published on: 01 March, 2012

Abeta DNA Vaccination for Alzheimers Disease: Focus on Disease Prevention

Volume:9   Issue: 2
Pp: 207-216
David H. Cribbs
DOI: 10.2174/187152710791012080
Published on: 01 March, 2012

Transglutaminase-Catalyzed Crosslinking in Neurological Disease: From Experimental Evidence to Therapeutic Inhibition

Volume:9   Issue: 2
Pp: 217-231
G. Hoffner, W. Andre, A. Vanhoutteghem, S. Soues and P. Djian
DOI: 10.2174/187152710791012107
Published on: 01 March, 2012

Novel Anti-Inflammatory and Neuroprotective Agents for Parkinsons Disease

Volume:9   Issue: 2
Pp: 232-240
Li Lu, Fengqiao Li and Xiaomin Wang
DOI: 10.2174/187152710791012035
Published on: 01 March, 2012

Treating Schizophrenia: Novel Targets for the Cholinergic System

Volume:9   Issue: 2
Pp: 241-256
T.T. Money, E. Scarr, M. Udawela, A.S. Gibbons, W.J. Jeon, M.S. Seo and B. Dean
DOI: 10.2174/187152710791012062
Published on: 01 March, 2012